| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 600276.CN | Jiangsu Hengrui Pharmaceuticals Co., Ltd | 56.7 | ¤59,301 | CN |
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 76.3 | ¤37,311 | CN |
| 300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 46.4 | ¤14,608 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 71.4 | ¤10,518 | CN |
| 000999.CN | China Resources Sanjiu Medical & Pharmac | 54.3 | ¤6,639 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 688179.CN | Shanghai Aladdin Biochemical Technology | 48.6 | ¤607 | CN |
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 59.6 | ¤648 | CN |
| 301277.CN | Newland Pharmaceutical Co., Ltd. Class A | 46.2 | ¤658 | CN |
| 688581.CN | Hangzhou AGS MedTech Co. Ltd. | 52.4 | ¤673 | CN |
| 601089.CN | Beijing Winsunny Pharmaceutical Co., Ltd | 51.6 | ¤687 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 600276.CN | Jiangsu Hengrui Pharmaceuticals Co., Ltd | 56.7 | 22 | CN |
| 000999.CN | China Resources Sanjiu Medical & Pharmac | 54.3 | 19 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 71.4 | 19 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 67.7 | 18 | CN |
| 300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 46.4 | 11 | CN |
| 600062.CN | China Resources Double-Crane Pharmaceuti | 56.2 | 11 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 75.0 | 10 | CN |
| 002262.CN | Jiangsu Nhwa Pharmaceutical Co., Ltd. Cl | 59.4 | 10 | CN |
| 600216.CN | Zhejiang Medicine Co., Ltd. Class A | 57.2 | 9 | CN |
| 600750.CN | Jiangzhong Pharmaceutical Co., Ltd. Clas | 65.6 | 9 | CN |
| Average Market Cap | ¤6,362 |
| Median Market Cap | ¤2,506 |
| Avg. 3 Mo. Dollar Vol. | ¤59,667,086 |
| Avg. 3 Mo. Trading Vol. | 10,497,529 |
| Last Rebalance Date | 06/16/2025 |
| Companies Replaced | 17 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 22.3 |
| Forward P/E Ratio (12 Mo.) | 19.0 |
| Price/Book Ratio | 3.5 |
| Avg. Revenue Chg. - 3 Yr | 38.1% |
| Avg. Op. Income Chg. - 3 Yr. | 65.5% |
| Avg. EPS Growth - 3 Yr. | 22.1% |
| Avg. EPS Growth - 1 Yr. | 15.1% |
| Avg. Operating Margin | 22.9% |
| Avg. LT Debt to Total Capital | 6.7% |
| Avg. Return on Equity | 16.1% |
| Dividend Yield | 1.9% |
| China Health Care Index | 61.83 |
| China | 100.0% |
